Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotic
1.2.9 Antidepressant
1.3 Market by Application
1.3.1 Global Geriatric Medicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicine Market Perspective (2018-2033)
2.2 Geriatric Medicine Growth Trends by Region
2.2.1 Global Geriatric Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Geriatric Medicine Historic Market Size by Region (2018-2023)
2.2.3 Geriatric Medicine Forecasted Market Size by Region (2024-2033)
2.3 Geriatric Medicine Market Dynamics
2.3.1 Geriatric Medicine Industry Trends
2.3.2 Geriatric Medicine Market Drivers
2.3.3 Geriatric Medicine Market Challenges
2.3.4 Geriatric Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicine Players by Revenue
3.1.1 Global Top Geriatric Medicine Players by Revenue (2018-2023)
3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicine Revenue
3.4 Global Geriatric Medicine Market Concentration Ratio
3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2022
3.5 Geriatric Medicine Key Players Head office and Area Served
3.6 Key Players Geriatric Medicine Product Solution and Service
3.7 Date of Enter into Geriatric Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicine Breakdown Data by Type
4.1 Global Geriatric Medicine Historic Market Size by Type (2018-2023)
4.2 Global Geriatric Medicine Forecasted Market Size by Type (2024-2033)
5 Geriatric Medicine Breakdown Data by Application
5.1 Global Geriatric Medicine Historic Market Size by Application (2018-2023)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Geriatric Medicine Market Size (2018-2033)
6.2 North America Geriatric Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Geriatric Medicine Market Size by Country (2018-2023)
6.4 North America Geriatric Medicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geriatric Medicine Market Size (2018-2033)
7.2 Europe Geriatric Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Geriatric Medicine Market Size by Country (2018-2023)
7.4 Europe Geriatric Medicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicine Market Size (2018-2033)
8.2 Asia-Pacific Geriatric Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Geriatric Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Geriatric Medicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geriatric Medicine Market Size (2018-2033)
9.2 Latin America Geriatric Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Geriatric Medicine Market Size by Country (2018-2023)
9.4 Latin America Geriatric Medicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicine Market Size (2018-2033)
10.2 Middle East & Africa Geriatric Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Geriatric Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Geriatric Medicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Geriatric Medicine Introduction
11.1.4 GSK Revenue in Geriatric Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
11.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Geriatric Medicine Introduction
11.3.4 Novartis Revenue in Geriatric Medicine Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Geriatric Medicine Introduction
11.5.4 Pfizer Revenue in Geriatric Medicine Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Geriatric Medicine Introduction
11.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Geriatric Medicine Introduction
11.7.4 Abbott Revenue in Geriatric Medicine Business (2018-2023)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Geriatric Medicine Introduction
11.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2018-2023)
11.8.5 AstraZeneca Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Geriatric Medicine Introduction
11.9.4 Merck Revenue in Geriatric Medicine Business (2018-2023)
11.9.5 Merck Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Detail
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Geriatric Medicine Introduction
11.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2018-2023)
11.10.5 Sanofi S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotic
Table 9. Key Players of Antidepressant
Table 10. Global Geriatric Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Geriatric Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Geriatric Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Geriatric Medicine Market Share by Region (2018-2023)
Table 14. Global Geriatric Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Geriatric Medicine Market Share by Region (2024-2033)
Table 16. Geriatric Medicine Market Trends
Table 17. Geriatric Medicine Market Drivers
Table 18. Geriatric Medicine Market Challenges
Table 19. Geriatric Medicine Market Restraints
Table 20. Global Geriatric Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Geriatric Medicine Market Share by Players (2018-2023)
Table 22. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2022)
Table 23. Ranking of Global Top Geriatric Medicine Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Geriatric Medicine Product Solution and Service
Table 27. Date of Enter into Geriatric Medicine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Geriatric Medicine Revenue Market Share by Type (2018-2023)
Table 31. Global Geriatric Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Geriatric Medicine Revenue Market Share by Type (2024-2033)
Table 33. Global Geriatric Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Geriatric Medicine Revenue Market Share by Application (2018-2023)
Table 35. Global Geriatric Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Geriatric Medicine Revenue Market Share by Application (2024-2033)
Table 37. North America Geriatric Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Geriatric Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Geriatric Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Geriatric Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Geriatric Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Geriatric Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Geriatric Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Geriatric Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Geriatric Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Geriatric Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Geriatric Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Geriatric Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Geriatric Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Geriatric Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Geriatric Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 52. GSK Company Detail
Table 53. GSK Business Overview
Table 54. GSK Geriatric Medicine Product
Table 55. GSK Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 56. GSK Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Geriatric Medicine Product
Table 60. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Geriatric Medicine Product
Table 65. Novartis Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Bristol-Myers Squibb Company Detail
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Geriatric Medicine Product
Table 70. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Geriatric Medicine Product
Table 75. Pfizer Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Eli Lilly Company Detail
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Geriatric Medicine Product
Table 80. Eli Lilly Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 81. Eli Lilly Recent Development
Table 82. Abbott Company Detail
Table 83. Abbott Business Overview
Table 84. Abbott Geriatric Medicine Product
Table 85. Abbott Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Geriatric Medicine Product
Table 90. AstraZeneca Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Merck Company Detail
Table 93. Merck Business Overview
Table 94. Merck Geriatric Medicine Product
Table 95. Merck Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Sanofi S.A. Company Detail
Table 98. Sanofi S.A. Business Overview
Table 99. Sanofi S.A. Geriatric Medicine Product
Table 100. Sanofi S.A. Revenue in Geriatric Medicine Business (2018-2023) & (US$ Million)
Table 101. Sanofi S.A. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Geriatric Medicine Market Share by Type: 2022 VS 2033
Figure 3. Analgesics Features
Figure 4. Antihypertensives Features
Figure 5. Statins Features
Figure 6. Antidiabetics Features
Figure 7. Proton Pump Inhibitor Features
Figure 8. Anticoagulant Features
Figure 9. Antipsychotic Features
Figure 10. Antidepressant Features
Figure 11. Global Geriatric Medicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Geriatric Medicine Market Share by Application: 2022 VS 2033
Figure 13. Cardiovascular Case Studies
Figure 14. Arthritis Case Studies
Figure 15. Neurological Case Studies
Figure 16. Cancer Case Studies
Figure 17. Osteoporosis Case Studies
Figure 18. Respiratory Case Studies
Figure 19. Geriatric Medicine Report Years Considered
Figure 20. Global Geriatric Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Geriatric Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Geriatric Medicine Market Share by Region: 2022 VS 2033
Figure 23. Global Geriatric Medicine Market Share by Players in 2022
Figure 24. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2022
Figure 26. North America Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Geriatric Medicine Market Share by Country (2018-2033)
Figure 28. United States Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Geriatric Medicine Market Share by Country (2018-2033)
Figure 32. Germany Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Geriatric Medicine Market Share by Region (2018-2033)
Figure 40. China Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Geriatric Medicine Market Share by Country (2018-2033)
Figure 48. Mexico Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Geriatric Medicine Market Share by Country (2018-2033)
Figure 52. Turkey Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Geriatric Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GSK Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 59. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 60. Abbott Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 61. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 63. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed